Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
5.08
-0.06 (-1.17%)
At close: Aug 15, 2025, 3:59 PM
5.00
-1.48%
After-hours: Aug 15, 2025, 07:53 PM EDT
Evoke Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 12.62M | 13.6M | 11.34M | 9.18M | 9.7M | 4.74M | 5.96M | 7.01M | 8.21M | 9.84M | 12.35M | 13.45M | 7.7M | 9.14M | 11.14M | 16.72M | 18.19M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 6.31K | 126.93K | 115.49K | n/a | n/a | 241.64K | n/a | -52.84K | -91.4K | -129.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 2.51M | 2.42M | 2.02M | 2M | 1.45M | 673.07K | 1.23M | 1.02M | 687.3K | 624.83K | 674.97K | 365.64K | 418.91K | 295.19K | 222.17K | 198.41K | 127.8K |
Inventory | 532.14K | 445.08K | 493.41K | 544.76K | 588.78K | 481.84K | 504.93K | 513.71K | 364.87K | 289.38K | 220.3K | 268.33K | 278.78K | 185.53K | 225.22K | 234.04K | 236.04K |
Other Current Assets | 39.24K | 43.9K | 36.42K | 27.68K | 6.31K | 47.53K | 98.09K | 11.55K | 11.55K | 11.55K | 11.55K | 11.55K | 11.55K | 11.55K | 11.55K | 11.7K | 11.7K |
Total Current Assets | 16.23M | 17.24M | 14.04M | 12.14M | 12.45M | 6.83M | 7.84M | 8.93M | 9.95M | 11.72M | 13.26M | 14.4M | 9.03M | 10.56M | 11.6M | 17.47M | 19.18M |
Property-Plant & Equipment | 138.76K | 154.18K | n/a | n/a | n/a | n/a | 13.37K | 52.84K | 91.4K | 129.07K | 153.67K | n/a | n/a | 12.43K | 49.12K | 84.93K | 119.93K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 145.07K | 281.11K | 115.49K | n/a | n/a | 241.64K | 13.37K | 52.84K | 91.4K | 129.07K | 153.67K | n/a | n/a | 12.43K | 49.12K | 84.93K | 119.93K |
Total Assets | 16.38M | 17.52M | 14.15M | 12.14M | 12.45M | 7.07M | 7.85M | 8.98M | 10.04M | 11.85M | 13.41M | 14.4M | 9.03M | 10.57M | 11.65M | 17.56M | 19.3M |
Account Payables | 2.78M | 2.34M | 2.19M | 1.9M | 1.64M | 1.71M | 1.4M | 1.42M | 1.19M | 868.31K | 1.02M | 824.48K | 944.48K | 874.03K | 530.53K | 519K | 691.23K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -5M | -1.4M | -1.42M | -1.19M | n/a | -140.3K | n/a | n/a | n/a | n/a | 5.62M | 5.43M |
Short-Term Debt | 5M | 5M | 5M | 5M | 5M | 5M | 13.37K | 52.84K | 91.4K | 129.07K | 140.3K | n/a | n/a | 12.43K | 49.12K | 84.93K | 119.93K |
Other Current Liabilities | 371.73K | 2.11M | 1.99M | 152K | 256K | -5M | 816.3K | 560.09K | 308.85K | 528.08K | 576.69K | n/a | n/a | 506.89K | 761.67K | -78.91K | -110.89K |
Total Current Liabilities | 10.45M | 10.38M | 9.77M | 9.47M | 8.96M | 3.04M | 2.24M | 2.08M | 1.68M | 1.65M | 1.88M | 1.35M | 1.36M | 1.41M | 1.39M | 6.23M | 6.25M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 1.61M | 1.49M | 1.36M | 1.24M | 1.11M | 986.27K | 860.24K | 735.58K | 612.29K | 486.27K | 360.24K | 235.58K |
Total Long-Term Liabilities | 83.22K | 100.96K | n/a | n/a | 6.74M | 6.61M | 6.49M | 6.36M | 6.24M | 6.11M | 6M | 5.86M | 5.74M | 5.61M | 5.49M | 5.36M | 5.24M |
Total Liabilities | 10.53M | 10.48M | 9.77M | 9.47M | 8.96M | 9.65M | 8.73M | 8.44M | 7.91M | 7.77M | 7.88M | 7.21M | 7.09M | 7.02M | 6.88M | 11.59M | 11.48M |
Total Debt | 5.14M | 5.16M | 5M | 5M | 5M | 5M | 5.01M | 5.05M | 5.09M | 5.13M | 5.15M | 5M | 5M | 5.01M | 5.05M | 5.08M | 5.12M |
Common Stock | 149.00 | 149.00 | 89.00 | 73.00 | 859.00 | 334.00 | 334.00 | 334.00 | 334.00 | 334.00 | 334.00 | 334.00 | 3.29K | 3.27K | 3.27K | 3.24K | 3.24K |
Retained Earnings | -130.1M | -128.79M | -127.6M | -126.29M | -125.02M | -123.44M | -121.45M | -119.76M | -117.89M | -115.65M | -113.84M | -111.83M | -109.6M | -107.42M | -105.75M | -103.78M | -101.49M |
Comprehensive Income | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | -0.00 | n/a | n/a | 0.00 | -0.00 | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 5.84M | 7.04M | 4.39M | 2.66M | 3.5M | -2.58M | -873.77K | 538.37K | 2.13M | 4.08M | 5.53M | 7.19M | 1.93M | 3.56M | 4.77M | 5.97M | 7.81M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |